Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses
- 10 October 1997
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 156 (1) , 79-88
- https://doi.org/10.1016/s0378-5173(97)00189-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 InfectionNew England Journal of Medicine, 1995
- Safety and activity of saquinavir in HIV infectionThe Lancet, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- Bioavailability of a Poorly Water-Soluble Drug from Tablet and Solid Dispersion in HumansJournal of Pharmaceutical Sciences, 1991
- Effect of Vehicle Amphiphilicity on the Dissolution and Bioavailability of a Poorly Water-Soluble Drug from Solid DispersionsJournal of Pharmaceutical Sciences, 1988
- Absorption Potential: Estimating the Fraction Absorbed for Orally Administered CompoundsJournal of Pharmaceutical Sciences, 1985